Mirixa Australia Launches at APP2009

New business unit, building on the success of Mirixa Corporation in the U.S., makes clinical technology to power pharmacist-delivered services available nationwide in Australia

Gold Coast, Queensland, Australia, April 3, 2009 – Mirixa Corporation, a U.S. leader in pharmacy-based patient care services and the Pharmacy Guild of Australia announced today the launch of Mirixa Australia at the Australian Pharmacy Professional Conference and Trade Exhibition. Mirixa Australia, a newly formed business venture is operated by the Guild’s healthlinks.net subsidiary.

The Guild will deploy the MirixaPro℠ web-based clinical platform, adapted by Mirixa Corporation for the Australia market, and made available under a nationwide license. Its first phase of deployment will bring to market programs designed to improve medication adherence and outcomes by harnessing both technology and the power of the pharmacist-patient relationship.

“Truly achieving better long-term medication adherence is the holy grail in pharmaceutical care,” said Kos Sclavos, National President of the Pharmacy Guild of Australia. “Pharmacists are ideally positioned to help patients – especially those with chronic disease – get the most from their medications. When they do so, everyone wins. We achieve better outcomes at a lower cost. We’re pleased to be working with our colleagues at Mirixa in the U.S. to achieve this shared global vision for improving healthcare through pharmacy,” added Mr. Sclavos.

“We’re thrilled to be working with the innovators and leaders at the Pharmacy Guild of Australia,” said Rick Solano, Mirixa’s Chief Executive Officer. “We see growing evidence and recognition globally that a fully integrated and effective healthcare system is one where pharmacists are actively engaged in patient care. We commend our colleagues at the Guild for reaching this key milestone on the road to achieving this shared vision,” added Mr. Solano.

“It’s through smart international partnerships that pharmacy will maintain their important place in the health care system,” said Bruce Roberts, CEO and Executive Vice President of NCPA. “The entry of Mirixa Australia into the Australia health care system is not only a testament to the vision of the Australia Pharmacy Guild, it’s a ringing endorsement of the value Mirixa Corporation provides its U.S. patients every day,” added Mr. Roberts.

About Mirixa
Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the healthcare community to deliver patient care services through community pharmacy. The MirixaPro℠ web-based clinical platform is used by pharmacists to deliver standardized patient care services. For more information, please visit www.Mirixa.com.

About The Pharmacy Guild of Australia
The Pharmacy Guild of Australia was established in 1928, is the peak organization representing the interests of community pharmacy in Australia. Its members are owners of some 4,500 pharmacies throughout Australia. The development of policy is the responsibility of the Guild's supreme governing body, the National Council, on which all State and Territory Branches are represented. Implementation of policy is overseen by the National Executive and effected through the National Secretariat. For more information please visit www.guild.org.au.

About NCPA
The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines. To learn more please visit www.ncpanet.org.